NOVEL HIV REVERSE TRANSCRIPTASE INHIBITORS

PURPOSE: A compound of suppressing a novel HIV reverse transcriptase is provided to suppress both wild type HIV strain and mutant type HIV strain and to treat AIDS. CONSTITUTION: A compound suppressing a novel HIV reverse trascriptase is denoted by chemical formula I. HIV infection is treated by mix...

Full description

Saved in:
Bibliographic Details
Main Authors GUO HONGYAN, SON, JONG CHAN, MITCHELL MICHAEL L, LEE, ILL YOUNG, KIM CHOUNG U, RHODES GERRY, XU LIANHONG
Format Patent
LanguageEnglish
Korean
Published 22.04.2010
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:PURPOSE: A compound of suppressing a novel HIV reverse transcriptase is provided to suppress both wild type HIV strain and mutant type HIV strain and to treat AIDS. CONSTITUTION: A compound suppressing a novel HIV reverse trascriptase is denoted by chemical formula I. HIV infection is treated by mixing a compound of chemical formula I, compound suppressing HIV protease, HIV non-nucleoside reverse transcriptase inhibitor, HIV nucleoside reverse transcriptase inhibitor, HIV nucleotide reverse transcriptase inhibitor, HIV integrase inhibitor, gp41 inhibitor, CXCR4 inhibitor, gp120 inhibitor, G6PD and NADH-oxidase inhibitor, CCR5 inhibitor, other HIV drug, or mixture thereof.
Bibliography:Application Number: KR20107002073